As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the portion-controlled snacks to meet their nutritional needs.

Medifast, Inc. MED, a prominent player in the health and wellness industry, is making significant strides to expand its ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...